Zhao, L.; Wang, Z.; Cheng, P.; Sheng, G.; Han, M.; Zheng, Z.
SMYD3–CDCP1 Axis Drives EMT and CAF Activation in Colorectal Cancer and Is Targetable for Oxaliplatin Sensitization. Biomedicines 2025, 13, 2737.
https://doi.org/10.3390/biomedicines13112737
AMA Style
Zhao L, Wang Z, Cheng P, Sheng G, Han M, Zheng Z.
SMYD3–CDCP1 Axis Drives EMT and CAF Activation in Colorectal Cancer and Is Targetable for Oxaliplatin Sensitization. Biomedicines. 2025; 13(11):2737.
https://doi.org/10.3390/biomedicines13112737
Chicago/Turabian Style
Zhao, Liming, Zhexue Wang, Pu Cheng, Guoli Sheng, Mingyu Han, and Zhaoxu Zheng.
2025. "SMYD3–CDCP1 Axis Drives EMT and CAF Activation in Colorectal Cancer and Is Targetable for Oxaliplatin Sensitization" Biomedicines 13, no. 11: 2737.
https://doi.org/10.3390/biomedicines13112737
APA Style
Zhao, L., Wang, Z., Cheng, P., Sheng, G., Han, M., & Zheng, Z.
(2025). SMYD3–CDCP1 Axis Drives EMT and CAF Activation in Colorectal Cancer and Is Targetable for Oxaliplatin Sensitization. Biomedicines, 13(11), 2737.
https://doi.org/10.3390/biomedicines13112737